March 11, 2013
The Application of EU Competition Law in the Pharmaceutical Sector: The Case of Parallel Trade
Posted by D. Daniel Sokol
Lazaros Grigorios Grigoriadis, Aristotle University of Thessaloniki describes The Application of EU Competition Law in the Pharmaceutical Sector: The Case of Parallel Trade.
ABSTRACT: Parallel trade traditionally enjoys a significant protection from European Institutions, in the belief that it fosters competition and encourages trade. However, pharmaceutical companies claim that this form of competition undermines their incentive to innovate and threatens the competitiveness of the European pharmaceutical sector. This Article analyses a) the arguments put forward in favour of and against the freedom of parallel trade of pharmaceuticals between the EU Member States and b) the case-law relating to parallel trade of pharmaceuticals developed by the EU courts and more specifically by the Court of Justice (“CJ”) (former Court Justice of the European Communities/“ECJ”)and by the General Court (“GC”) (former Court of First Instance of the European Communities/“CFI”) in the light of the EU competition law (Articles 101-102 of the TFEU).
March 11, 2013 | Permalink
TrackBack URL for this entry:
Listed below are links to weblogs that reference The Application of EU Competition Law in the Pharmaceutical Sector: The Case of Parallel Trade: